Ikarian Capital, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$735.3B
Holdings
147
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (147 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | LYELLYELL IMMUNOPHARMA INC | 1,276,037 | $816.7M | 0.11% | |
| 102 | CMPSCOMPASS PATHWAYS PLC | 202,894 | $766.9M | 0.10% | |
| 103 | AMLXAMYLYX PHARMACEUTICALS INC | 201,187 | $760.5M | 0.10% | |
| 104 | KZRKEZAR LIFE SCIENCES INC | 106,901 | $718.4M | 0.10% | |
| 105 | CATXPERSPECTIVE THERAPEUTICS INC | 215,500 | $687.4M | 0.09% | Put |
| 106 | NRIXNURIX THERAPEUTICS INC | 34,985 | $659.1M | 0.09% | |
| 107 | PHGEBIOMX INC | 892,976 | $652.0M | 0.09% | |
| 108 | INBXINHIBRX BIOSCIENCES INC | 42,122 | $648.7M | 0.09% | |
| 109 | AEMDEURAETHLON MED INC | 750,000 | $645.0M | 0.09% | |
| 110 | VERUEURVERU INC | 945,239 | $614.9M | 0.08% | |
| 111 | CRBPCORBUS PHARMACEUTICALS HLDGS | 51,431 | $606.9M | 0.08% | |
| 112 | 5E7ITEOS THERAPEUTICS INC | 78,585 | $603.5M | 0.08% | |
| 113 | OLMAOLEMA PHARMACEUTICALS INC | 91,994 | $536.3M | 0.07% | |
| 114 | ABOSACUMEN PHARMACEUTICALS INC | 265,769 | $457.1M | 0.06% | |
| 115 | BRD1EURMIND MEDICINE MINDMED INC | 62,691 | $436.3M | 0.06% | |
| 116 | SPRBSPRUCE BIOSCIENCES INC | 1,000,000 | $420.0M | 0.06% | |
| 117 | TVTXTRAVERE THERAPEUTICS INC | 22,600 | $393.7M | 0.05% | |
| 118 | —ELEVATION ONCOLOGY INC | 690,050 | $388.2M | 0.05% | |
| 119 | CMMBCHEMOMAB THERAPEUTICS LTD | 213,052 | $385.6M | 0.05% | |
| 120 | SNSEEURSENSEI BIOTHERAPEUTICS INC | 649,963 | $318.5M | 0.04% | |
| 121 | VYGRVOYAGER THERAPEUTICS INC | 55,766 | $316.2M | 0.04% | |
| 122 | CLYMCLIMB BIO INC | 175,088 | $315.2M | 0.04% | |
| 123 | ATXIAVENUE THERAPEUTICS INC | 140,000 | $280.0M | 0.04% | |
| 124 | KPTIEURKARYOPHARM THERAPEUTICS INC | 408,899 | $276.5M | 0.04% | |
| 125 | ANEBANEBULO PHARMACEUTICALS INC | 157,720 | $265.0M | 0.04% | |
| 126 | MGNXMACROGENICS INC | 80,071 | $260.2M | 0.04% | |
| 127 | VTGNVISTAGEN THERAPEUTICS INC | 77,616 | $229.0M | 0.03% | |
| 128 | LRMRLARIMAR THERAPEUTICS INC | 58,526 | $226.5M | 0.03% | |
| 129 | NUVBNUVATION BIO INC | 83,407 | $221.9M | 0.03% | |
| 130 | LYRALYRA THERAPEUTICS INC | 1,058,148 | $218.4M | 0.03% | |
| 131 | QNRXQUOIN PHARMACEUTICALS LTD | 275,000 | $178.9M | 0.02% | |
| 132 | AEONAEON BIOPHARMA INC | 257,563 | $139.1M | 0.02% | |
| 133 | MNPRMONOPAR THERAPEUTICS INC | 5,908 | $130.0M | 0.02% | |
| 134 | APLSAPELLIS PHARMACEUTICALS INC | 3,594 | $114.7M | 0.02% | |
| 135 | HOOKHOOKIPA PHARMA INC | 52,996 | $106.5M | 0.01% | |
| 136 | OVASUSDTEMPEST THERAPEUTICS INC | 105,285 | $87.9M | 0.01% | |
| 137 | AMIXAUTONOMIX MED INC | 20,000 | $75.2M | 0.01% | |
| 138 | STOKSTOKE THERAPEUTICS INC | 6,798 | $75.0M | 0.01% | |
| 139 | CADLCANDEL THERAPEUTICS INC | 8,600 | $74.6M | 0.01% | Put |
| 140 | SGMTSAGIMET BIOSCIENCES INC | 11,984 | $53.9M | 0.01% | |
| 141 | SYBXSYNLOGIC INC | 20,422 | $28.0M | 0.00% | |
| 142 | RLMDRELMADA THERAPEUTICS INC | 40,270 | $20.9M | 0.00% | |
| 143 | GHDBRAINSTORM CELL THERAPEUTICS | 6,016 | $13.7M | 0.00% | |
| 144 | CTMXCYTOMX THERAPEUTICS INC | 8,924 | $9.2M | 0.00% | |
| 145 | EWTXEDGEWISE THERAPEUTICS INC | 200 | $5.3M | 0.00% | Put |
| 146 | GLYCEURGLYCOMIMETICS INC | 6,501 | $1.6M | 0.00% | |
| 147 | FDMT4D MOLECULAR THERAPEUTICS IN | 40 | $223K | 0.00% |
PreviousPage 2 of 2